striae distensae. Striae atrophicae
Conditions
Interventions
Intervention 1: Intervention group 1: combination of erbium Yag laser and intralesional injection of stromal vascular fraction (SVF). Erbium YAG laser usually selectively targets hydrous tissue with l
Sponsors
Skin and Stem Cell Research Center of Tehran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 50 Years
Inclusion criteria
Inclusion criteria: The diagnosis of stria distensa based on the diagnosis of a dermatologist Age less than 50 years and more than 18 years
Exclusion criteria
Exclusion criteria: Using any treatment method to remove striae in the last three months Presence of lesions and skin diseases such as skin cancer or infections Presence of collagen vascular diseases Pregnancy and lactation Using steroids or immunosuppressive drugs
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pigmentation (color of the lesion). Timepoint: 3 months after the treatment. Method of measurement: Biometry with Colorimeter 4000, Multi Probe Adaptor System 5 (MPA5).;Elasticity of the skin. Timepoint: 3 months after the treatment. Method of measurement: Biometry with Cutometer, Multi Probe Adaptor System 580 (MPA580). | — |
Secondary
| Measure | Time frame |
|---|---|
| Patient satisfaction. Timepoint: 3 months after the treatment. Method of measurement: Based on patient global assessment score.;Complications. Timepoint: 3 months after the treatment. Method of measurement: Using a checklist containing treatment complications including pain, erythema and edema. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMasoumeh Roohaninasab
Iran University of Medical Sciences
Outcome results
None listed